Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine

Update Il y a 4 ans
Reference: NCT00825058

Woman and Man

Extract

Primary objective : - To demonstrate the antidepressant efficacy on the Hamilton Depression Rating Scale of SR58611A 700mg/day compared with placebo in the treatment of patients with a recurrent major depressive episode. Secondary objectives: - To assess the safety profile of SR58611A 700 mg/d in comparison to placebo and to assess plasma concentrations of the active metabolite.


Inclusion criteria

  • Major Depressive Disorders


Links